Skip to main
6 Followers • 8 Following


@ucanttopmyramenHealthcare Education
  1. Asset
  2. PLRX
    Pliant Therapeutics
  3. AC Immune
  4. ACADIA Pharma
  5. ADC Therapeutics
  6. ALX Onconology Holdings Inc
  7. AMC Entertainment
  8. AN2 Therapeutics Inc
  9. ARK Fintech Innovation ETF
  10. ARM Holdings PLC
  11. AST SpaceMobile
  12. AT&T
  13. AXT
  14. AbbVie
  15. Abbott Labs
  16. Adobe
  17. Agba Acquisition Ltd
  18. Agilysys
  19. Agriforce Growing Systems Ltd
  20. Agrify
  21. Airbnb
  22. Akili Inc
  23. Alaska Air Group
  24. Alibaba
  25. Allbirds
  26. Allego NV
  27. Alliance Entertainment Holding Corp
  28. Allied Gaming & Entertainment Inc
  29. Allurion Technologies Holdings Inc
  30. Ally Financial
  31. Alnylam Pharmaceuticals
  32. Alphabet
  33. Alphabet
  34. Amalgamated Financial Corp
  35. Amazon
  36. Ambarella
  37. Ambev
  38. American Rebel Holdings Inc
  39. Ampio Pharmaceuticals Inc
  40. Apple
  41. Asensus Surgical
  42. AstraZeneca
  43. Atai Life Sciences BV
  44. Aurora Cannabis
  45. Axsome Therapeutics
  46. BAIYU Holdings Inc
  47. Babcock & Wilcox Enterprises
  48. Barnes & Noble Education
  49. Beneficient
  50. Benitec Biopharma Limited Sponsored ADR
  51. Berkshire Hathaway
  52. Better Home & Finance Holding Co
  53. BioNTech SE
  54. BioVie Inc
  55. Birkenstock Holding Plc
  56. Birks Group
  57. Bit Brother Ltd
  58. Bite Acquisition Corp
  59. Bitfarms Ltd
  60. Bitwise Crypto Innovators ETF
  61. Blink Charging
  62. Block
  63. Bloom Energy
  64. Bolt Biotherapeutics
  65. Boston Beer Company
  66. Brand Engagement Network Inc
  67. Broadcom
  68. Broadwind Energy
  69. Brooge Energy Limited
  71. C4 Therapeutics
  72. COMPASS Pathways
  73. Caesars Entertainment
  74. Cameco
  75. Canopy Growth
  76. Capital One
  77. Captivision Inc
  78. Carmell Therapeutics Corp
  79. Carnival
  80. Cassava Sciences Inc
  81. Cava Group, Inc.
  82. Celsius Holdings
  83. Centrus Energy
  84. Checkpoint Therapeutics
  85. Cheetah Net Supply Chain Service Inc
  86. Chewy
  87. China Rapid Finance
  88. Cibus Inc
  89. Cidara Therapeutics
  90. Clear Secure
  91. ClimateRock
  92. Coca-Cola Bottling
  93. Codexis
  94. Coherus BioSciences
  95. Comcast
  96. Complete Solaria Inc
  97. Compugen
  98. Comtech Telecommunications
  99. Connect Biopharma Holdings
  100. Corcept Therapeutics
  101. Corvus Pharmaceuticals
  102. Critical Metals Corp
  103. Cronos Group
  104. Cue Biopharma
  105. Cue Health Inc
  106. Cybin
  107. Dave
  108. Dave & Buster's
  109. Denison Mines
  110. Dick's Sporting Goods
  111. Digital Ally Inc
  112. Direct Digital Holdings
  113. Direxion Daily Electric & Autonomous Vehicles Bull 2X Shares
  114. Disney
  115. Dollar Tree
  116. DoorDash
  117. DraftKings
  118. Draganfly Inc
  119. Dyne Therapeutics
  120. EDAP TMS
  121. EOG Resources
  122. ESSA Pharma
  123. Eaton Vance Enhanced Equity Income Fund
  124. Ebix Inc
  125. EchoStar
  126. Edgio Inc
  127. Eli Lilly
  128. Emergent BioSolutions
  129. Encompass Health
  130. Endeavor Group Holdings
  131. Energy Fuels
  132. Engene Holdings Inc
  133. Envoy Medical Inc
  134. Equillium Inc
  135. FibroGen
  136. First Trust India NIFTY 50 Equal Weight ETF
  137. FlexShares STOXX US ESG Impact Index Fund
  138. Forward Industries
  139. Frequency Therapeutics Inc
  140. Freyr Battery Inc
  141. FuboTV
  142. G1 Therapeutics
  143. GH Research PLC
  144. Gain Therapeutics
  145. Group
  146. GameStop
  147. Generation Bio
  148. Global X Artificial Intelligence & Technology ETF
  149. Global X Robotics & Artificial Intelligence ETF
  150. Global X Uranium ETF
  151. Globe Life Inc
  152. HeartBeam
  153. Helix Energy Solutions Group
  154. Hims & Hers Health
  155. Hologic
  156. Hub Cyber Security Ltd
  157. Immix Biopharma
  158. Imperial Petroleum
  159. Indivior PLC
  160. Intellicheck
  161. Intensity Therapeutics Inc
  162. Intuitive Machines Inc
  163. Intuitive Surgical
  164. Invesco QQQ
  165. Ispire Technology Inc
  166. Janux Therapeutics
  167. Joby Aviation
  168. Just Eat NV
  169. Kennedy-Wilson Holdings
  170. Keros Therapeutics
  171. Laser Photonics Corp
  172. Legacy Housing Corp
  173. Lemonade
  174. Leonardo DRS Inc
  175. Lexicon Pharmaceuticals
  176. Live Nation
  177. Logistic Properties Of The Americas
  178. Lytus Technologies Holdings PTV Ltd
  179. MGM Resorts
  180. MannKind
  181. Maravai LifeSciences Holdings
  182. Mattel
  183. Matterport
  184. MercadoLibre
  185. Merck
  186. Mesoblast
  187. Meta
  188. Microsoft
  189. Mind Medicine MindMed
  190. Mmtec Inc
  191. Moderna
  192. ModivCare
  193. Modular Medical
  194. Molson Coors Brewing
  195. Momentus
  196. Montana Technologies Corporation
  197. Monte Rosa Therapeutics
  198. Moog
  199. Moolec Science SA
  200. Murano Global BV
  201. NANO Nuclear Energy Inc
  202. NIKE
  203. NVIDIA
  204. Nauticus Robotics Inc
  205. Nektar Therapeutics
  206. NeoVolta Inc
  207. NerdWallet
  208. Netflix
  209. NeueHealth Inc
  210. New Providence Acquisition Corp II
  211. Newegg Commerce
  212. Nifty India Financials ETF
  213. Nine Energy Service
  214. Noco-Noco Inc
  215. Novartis
  216. Novavax
  217. Novo Nordisk
  218. NuScale Power Corp
  219. Ocean Biomedical Inc
  220. Olink Holding AB
  221. Omega Therapeutics
  222. Owlet
  223. Palantir Technologies
  224. Palo Alto Networks
  225. Panbela Therapeutics Inc
  226. Paramount Global
  227. PayPal
  228. Penn Entertainment
  229. PepGen Inc
  230. PepsiCo
  231. Perion Network
  232. Perrigo
  233. Pfizer
  234. Pinduoduo Inc - ADR
  235. Pinstripes Holdings Inc
  236. Pitney Bowes
  237. Pixelworks
  238. Privia Health Group
  239. ProShares UltraPro QQQ
  240. Progyny
  241. Quantasing Group Ltd
  242. QuantumScape
  243. RLX Technology
  244. Rani Therapeutics Holdings
  245. Reddit Inc
  246. Regeneron Pharmaceuticals
  247. Repare Therapeutics
  248. Restaurant Brands
  249. Rigel Pharmaceuticals
  250. Riot Blockchain
  251. Rocket Lab USA
  252. Rocky Brands
  253. Roundhill Generative AI & Technology ETF
  254. SAGE Therapeutics
  255. SHF Holdings Inc
  256. Sanmina-SCI
  257. Sanofi
  258. Sarepta Therapeutics
  259. Scinai Immunotherapeutics Ltd
  260. Seelos Therapeutics
  261. Seres Therapeutics
  262. Shattuck Labs
  263. Shengfeng Development Ltd
  264. Shiba Inu
  265. Shimmick Corp
  266. Shineco
  267. Skechers U.S.A.
  268. Sleep Number
  269. SoFi Technologies
  270. Solidion Technology Inc
  271. Sonoma Pharmaceuticals
  272. SoundHound AI Inc
  273. Sprott Uranium Miners ETF
  274. Spyre Therapeutics Inc
  275. Strive US Energy ETF
  276. Stronghold Digital Mining
  277. Summit Wireless Technologies Inc
  278. Super League Enterprise Inc
  279. Symbotic Inc
  280. TFF Pharmaceuticals
  281. Taiwan Semiconductor Manufacturing
  282. Telomir Pharmaceuticals Inc
  283. Tema Obesity & Cardiometabolic ETF
  284. Tesla
  285. Teva Pharmaceutical
  286. The Arena Group Holdings
  287. Theravance Biopharma
  288. Topgolf Callaway Brands Corp
  289. Travere Therapeutics
  290. Tupperware
  291. Uber
  292. United Overseas Bank Ltd
  293. Unity Biotechnology Inc
  294. Upstart Holdings
  295. Upwork Inc
  296. Ur-Energy
  297. Uranium Royalty Corp
  298. Vast Solar Pty Ltd
  299. Verastem
  300. Verona Pharma
  301. Vertex Pharmaceuticals
  302. ViaSat
  303. Vicarious Surgical
  304. Vigil Neuroscience
  305. Viking Therapeutics
  306. Vintage Wine Estates
  307. Virco Mfg.
  308. Vivani Medical Inc
  309. Walgreens
  310. Walmart
  311. Wayfair
  312. Weightwatchers International Inc.
  313. Werewolf Therapeutics
  314. Xeris Biopharma Holdings
  315. iShares PHLX Semiconductor ETF
  316. iShares Robotics & Artificial Intelligence Multisector ETF
  1. Asset
  2. 10X Genomics
  3. AP Moller - Maersk A/S
  4. ARK Industrial Innovation ETF
  5. ASML Hld
  6. Aceragen Inc
  7. Altria
6 Followers • 8 Following


@ucanttopmyramenHealthcare Education
Joni avatar

All of your investing.
All in one place.

Invest in stocks, treasuries, ETFs, crypto, and alternative assets on Public. Transfer your account to Public and get up to $10,000.
Sign Up
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2024 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Product offerings and availability vary based on jurisdiction.

Stocks, ETFs, Options, Bonds.
Self-directed brokerage accounts and brokerage services for US-listed, registered securities, options, and Bonds, except for treasury securities offered through Jiko Securities, Inc., are offered to self-directed customers by Open to the Public Investing, Inc. (“Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Public Investing is not registered. Securities products offered by Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here.

Certain requirements must be met in order to trade options. Options can be risky and are not suitable for all investors. Options transactions are often complex, and investors can rapidly lose the entire amount of their investment or more in a short period of time. Investors should consider their investment objectives and risks carefully before investing in options. Refer to the Characteristics and Risks of Standardized Options before considering any options transaction. Supporting documentation for any claims, if applicable, will be furnished upon request. Tax considerations with options transactions are unique and investors considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.

Options Order Flow Rebate.
If you are enrolled in our Options Order Flow Rebate Program, Public Investing will share 50% of our estimated order flow revenue for each completed options trade as a rebate to help reduce your trading costs. The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions.

“Bonds” shall refer to corporate debt securities and U.S. government securities offered on the Public platform through a self-directed brokerage account held at Public Investing and custodied at Apex Clearing. For purposes of this section, Bonds exclude treasury securities held in treasury accounts with Jiko Securities, Inc. as explained under the “ Treasury Accounts” section.

Investments in Bonds are subject to various risks including risks related to interest rates, credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications and other factors. The value of Bonds fluctuate and any investments sold prior to maturity may result in gain or loss of principal. In general, when interest rates go up, Bond prices typically drop, and vice versa. Bonds with higher yields or offered by issuers with lower credit ratings generally carry a higher degree of risk. All fixed income securities are subject to price change and availability, and yield is subject to change. Bond ratings, if provided, are third party opinions on the overall bond's credit worthiness at the time the rating is assigned. Ratings are not recommendations to purchase, hold, or sell securities, and they do not address the market value of securities or their suitability for investment purposes.

High-Yield Cash Account.
A High-Yield Cash Account is a secondary brokerage account with Public Investing. Funds in your High-Yield Cash Account are automatically deposited into partner banks (“Partner Banks”), where that cash earns interest and is eligible for FDIC insurance. See here for a list of current Partner Banks. Your Annual Percentage Yield is variable and may change at the discretion of the Partner Banks or Public Investing. Apex Clearing and Public Investing receive administrative fees for operating this program, which reduce the amount of interest paid on swept cash. Neither Public Investing nor any of its affiliates is a bank. Learn more.

Alternative Assets.
Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in a Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public Investing, and Public Investing (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency trading, execution, and custody services are provided by Bakkt Crypto Solutions, LLC (NMLS ID 1828849) (“Bakkt”). Cryptocurrency is highly speculative, involves a high degree of risk, and has the potential for loss of the entire amount of an investment. Cryptocurrencies offered by Bakkt are not securities and are not FDIC insured or protected by SIPC. Your cryptocurrency assets are held in your Bakkt account. Bakkt is a licensed virtual currency business by the New York State Department of Financial Services and a licensed money transmitter, but is not a registered broker-dealer or a FINRA member. Your Bakkt Crypto account is separate from your brokerage account with Public Investing, which holds US-listed stocks and ETFs. Please review the Risk Disclosures before trading.

Treasury Accounts.
Investing services in treasury accounts offering 6 month US Treasury Bills on the Public platform are through Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC. See JSI’s FINRA BrokerCheck and Form CRS for further information.

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). T-bills are purchased at a discount to the par value and the T-bill’s yield represents the difference in price between the “par value” and the “discount price.” Aggregate funds in your Treasury Account in excess of the T-bill purchases will remain in your Treasury Account as cash. The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability - yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates. Although T-bills are considered safer than many other financial instruments, you could lose all or a part of your investment. See Jiko U.S. Treasuries Risk Disclosures for further details.

Investments in T-bills: Not FDIC Insured; No Bank Guarantee; May Lose Value.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. You should consult your legal, tax, or financial advisors before making any financial decisions. This material is not intended as a recommendation, offer, or solicitation to purchase or sell securities, open a brokerage account, or engage in any investment strategy.

Commission-free trading refers to $0 commissions charged on trades of US listed registered securities placed during the US Markets Regular Trading Hours in self-directed brokerage accounts offered by Public Investing. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Public’s Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

Investment Plans. US members only. Investment Plans (“Plans”) shown in our marketplace are for informational purposes only and are meant as helpful starting points as you discover, research and create a Plan that meets your specific investing needs. Plans are self-directed purchases of individually-selected assets, which may include stocks, ETFs and cryptocurrency. Plans are not recommendations of a Plan overall or its individual holdings or default allocations. Plans are created using defined, objective criteria based on generally accepted investment theory; they are not based on your needs or risk profile. You are responsible for establishing and maintaining allocations among assets within your Plan. Plans involve continuous investments, regardless of market conditions. Diversification does not eliminate risk. See our Investment Plans Terms and Conditions and Sponsored Content and Conflicts of Interest Disclosure.

Market Data. Quotes and other market data for Public’s product offerings are obtained from third party sources believed to be reliable, but Public makes no representation or warranty regarding the quality, accuracy, timeliness, and/or completeness of this information. Such information is time sensitive and subject to change based on market conditions and other factors. You assume full responsibility for any trading decisions you make based upon the market data provided, and Public is not liable for any loss caused directly or indirectly by your use of such information. Market data is provided solely for informational and/or educational purposes only. It is not intended as a recommendation and does not represent a solicitation or an offer to buy or sell any particular security.